Osteopontin as a potential diagnostic biomarker for ovarian cancer.
about
p150(Sal2) is a p53-independent regulator of p21(WAF1/CIP)Beyond CA125: the coming of age of ovarian cancer biomarkersOPN -RevisitedDiagnostic value of osteopontin in ovarian cancer: a meta-analysis and systematic reviewIncreased expression of osteopontin gene in atypical teratoid/rhabdoid tumor of the central nervous systemOsteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune responseLarge-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serumMass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations.Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancerIdentification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis.Progress and challenges in screening for early detection of ovarian cancer.Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer.Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK/MAPK pathwayMolecular diagnostics: a new frontier in cancer prevention.VSGP/F-spondin: a new ovarian cancer marker.Classification of cancer cell lines using an automated two-dimensional liquid mapping method with hierarchical clustering techniques.Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system.Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancerE2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancerAqueous two-phase system patterning of detection antibody solutions for cross-reaction-free multiplex ELISAPathogenesis of ovarian cancer: clues from selected overexpressed genes.Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cellsReduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.Serum protein markers for early detection of ovarian cancerA new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissueDeep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer.FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth.Early detection of ovarian cancerCancer biomarkers: can we turn recent failures into success?Discovery of prognostic factors for diagnosis and treatment of epithelial-derived ovarian cancer from laying hens.Measuring the effect of inter-study variability on estimating prediction error.Immunoreactivity of anti-gelsolin antibodies: implications for biomarker validation.Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.Identification of ovarian cancer associated genes using an integrated approach in a Boolean framework.Clinical proteomics: translating benchside promise into bedside reality.Identification of diagnostic serum protein profiles of glioblastoma patientsNidogen-2: a new serum biomarker for ovarian cancerFunctional characterization of OPN in human laryngeal squamous cell carcinoma and its xenograft model in nude miceFeed forward artificial neural network: tool for early detection of ovarian cancer.Promising directions for the diagnosis and management of gynecological cancers.
P2860
Q24623684-E13F3999-C1CA-4A39-AC44-10F0BCBBB973Q24651567-5217BA64-7506-4B6F-9FD6-6C1932BEB7D8Q26798763-EA8DD99C-4E9D-4BD4-8085-D9C1F63F8248Q28082845-1B281EFE-2CD9-49A0-8BB7-C12DB2CB1A71Q28240435-A3940886-4451-4AB7-96C8-FC48C1B97BD8Q28267161-D8233349-85C6-40B5-A26F-1D477101953FQ30452357-F67815D5-B9B3-4B01-8168-3714511FA931Q30751781-11414F9D-350A-47D8-A41F-4395A802E1D5Q30763413-B77130A0-2D7E-4756-B7EE-30053152320FQ31005059-B5AC1C19-7175-4009-8CE0-6A22000D4778Q31041170-8F7C5276-43D7-491F-A0FF-2AE0BB53FCF6Q31154011-B1C64A97-73B0-46C0-A381-AB55608CDB36Q31172625-EA94FFA0-AD90-4C0C-870B-BAE9A5E8EE1EQ33204338-89FF370E-E912-45AD-8171-23EE422C9C36Q33221792-FC4D30E4-5D24-4A50-901F-3B7F9DA75314Q33222790-F885B43C-3C22-49D7-A27C-C3AF3D7ABC4EQ33254071-9D7CA763-6A22-43E9-B100-98A4EB6095ADQ33317638-5AAB33CB-2039-4CE1-B65B-6E9A443E8533Q33533979-4016F009-58FD-4A48-8D64-8E76C3B1B43AQ33554539-480C7980-8999-4EB5-947D-02CEDB0F430EQ33651139-F58A881C-E74C-4AB9-B19D-275396E37CF2Q33675150-DD36AE47-FE3F-4020-BE9F-0B997B80082DQ33710746-2BB64AC1-64BF-417C-8D63-3FC5E8B4D2BBQ33836343-D3A955F0-1048-47D4-9506-A9DF9A16D404Q33889245-C8B3F436-0117-4355-8B7D-7A0658E6FC8EQ33915813-0FA9B6E5-A700-4D3D-A97D-97D27AEA874CQ34021043-8C4137BD-0737-47C5-9562-7114B9C90076Q34094731-AED2A9BB-0549-40AF-9FBC-9C78EF0B12D3Q34176379-41A3749A-A8FF-4236-9CC3-038384C99D27Q34305434-47BA18F6-E336-41EB-96F0-E1BD44C721CDQ34362371-0374B81D-EFC8-4330-9F5C-393CFBBEFC8EQ34481890-0B91A8EF-E73F-454A-A85B-D956F48F3AADQ34482255-778DE42B-F514-43B8-BF76-650AF5829E51Q34577355-B345695E-2F8C-40F4-8DD1-B22535481920Q34810370-1FBA15FF-9020-4852-984F-02E3EA172FFCQ34981475-10CDB96A-B9FF-4452-B467-0E951F4E8FF0Q35030339-1DEF0FBB-2139-4448-B956-1808DB8E0E5FQ35173409-0FE6989E-0901-4FDA-AA7D-414851315114Q35185305-302A3609-949A-4C03-A7D0-13A81808BA0CQ35648859-7586F161-8BC8-4572-AE89-99D013EEA4E1
P2860
Osteopontin as a potential diagnostic biomarker for ovarian cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Osteopontin as a potential diagnostic biomarker for ovarian cancer.
@en
type
label
Osteopontin as a potential diagnostic biomarker for ovarian cancer.
@en
prefLabel
Osteopontin as a potential diagnostic biomarker for ovarian cancer.
@en
P2093
P356
P1476
Osteopontin as a potential diagnostic biomarker for ovarian cancer.
@en
P2093
Colleen M Feltmate
Daniel W Cramer
Jae-Hoon Kim
John O Schorge
Kwong-kwok Wong
Ross S Berkowitz
Samuel C Mok
Steven J Skates
Toshimitsu Uede
P304
P356
10.1001/JAMA.287.13.1671
P407
P577
2002-04-01T00:00:00Z